Mary Ann Liebert: Emerging Role of Adenosine in Brain Disorders and Amyotrophic Lateral Sclerosis
December 06, 2019
December 06, 2019
NEW ROCHELLE, New York, Dec. 6 -- Mary Ann Liebert Inc. issued the following news release:
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS). These are just two areas of focus in the upcoming special issue on Adenosine and Neurodegeneration - Part II published in Journal . . .
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS). These are just two areas of focus in the upcoming special issue on Adenosine and Neurodegeneration - Part II published in Journal . . .